ArticleEClinicalMedicine2023

A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study.

Geoffrey Herkes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.